JP2009521414A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009521414A5 JP2009521414A5 JP2008545772A JP2008545772A JP2009521414A5 JP 2009521414 A5 JP2009521414 A5 JP 2009521414A5 JP 2008545772 A JP2008545772 A JP 2008545772A JP 2008545772 A JP2008545772 A JP 2008545772A JP 2009521414 A5 JP2009521414 A5 JP 2009521414A5
- Authority
- JP
- Japan
- Prior art keywords
- crystal form
- temperature
- powder
- ray diffraction
- cukα
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013078 crystal Substances 0.000 claims 35
- 238000000634 powder X-ray diffraction Methods 0.000 claims 10
- 238000002411 thermogravimetry Methods 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 7
- 238000001144 powder X-ray diffraction data Methods 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 238000010586 diagram Methods 0.000 claims 4
- 238000000113 differential scanning calorimetry Methods 0.000 claims 4
- 238000001757 thermogravimetry curve Methods 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 1
- 150000004683 dihydrates Chemical class 0.000 claims 1
- 150000004689 octahydrates Chemical class 0.000 claims 1
- SWMDAPWAQQTBOG-UHFFFAOYSA-N Cc(nc1)n[n]1-c(c1c2c(C(C(N(CC3)CCN3C(c3ccccc3)=O)=O)=O)c[n]1COP(O)(O)=O)ncc2OC Chemical compound Cc(nc1)n[n]1-c(c1c2c(C(C(N(CC3)CCN3C(c3ccccc3)=O)=O)=O)c[n]1COP(O)(O)=O)ncc2OC SWMDAPWAQQTBOG-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75024705P | 2005-12-14 | 2005-12-14 | |
| US60/750,247 | 2005-12-14 | ||
| PCT/US2006/047571 WO2007070589A2 (en) | 2005-12-14 | 2006-12-13 | Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1h-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009521414A JP2009521414A (ja) | 2009-06-04 |
| JP2009521414A5 true JP2009521414A5 (enExample) | 2010-01-21 |
| JP5400387B2 JP5400387B2 (ja) | 2014-01-29 |
Family
ID=38163502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008545772A Active JP5400387B2 (ja) | 2005-12-14 | 2006-12-13 | １−ベンゾイル−４−［２−［４−メトキシ−７−（３−メチル−１ｈ−１，２，４−トリアゾール−１−イル）−１−［（ホスホノオキシ）メチル］−１ｈ−ピロロ［２，３−ｃ］ピリジン−３−イル］−１，２−ジオキソエチル］−ピペラジンの結晶形 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7851476B2 (enExample) |
| EP (1) | EP1963342A2 (enExample) |
| JP (1) | JP5400387B2 (enExample) |
| KR (1) | KR20080077010A (enExample) |
| CN (1) | CN101365708B (enExample) |
| AU (1) | AU2006326432B2 (enExample) |
| BR (1) | BRPI0619851A2 (enExample) |
| CA (1) | CA2635717A1 (enExample) |
| EA (1) | EA014706B1 (enExample) |
| GE (1) | GEP20125413B (enExample) |
| IL (1) | IL191769A (enExample) |
| MY (1) | MY144293A (enExample) |
| NO (1) | NO20082477L (enExample) |
| NZ (2) | NZ592684A (enExample) |
| UA (1) | UA94928C2 (enExample) |
| WO (1) | WO2007070589A2 (enExample) |
| ZA (1) | ZA200805063B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040110785A1 (en) * | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US7745625B2 (en) * | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| CN102076686B (zh) * | 2008-06-25 | 2013-03-06 | 百时美施贵宝公司 | 作为hiv附着抑制剂的二酮哌啶衍生物 |
| WO2009158394A1 (en) * | 2008-06-25 | 2009-12-30 | Bristol-Myers Squibb Company | Diketo azolopiperidines and azolopiperazines as anti-hiv agents |
| ES2383149T3 (es) * | 2008-09-04 | 2012-06-18 | Bristol-Myers Squibb Company | Composicion farmacéutica estable para la administración optimizada de un inhibidor de la unión del VIH |
| ES2585396T3 (es) | 2010-12-02 | 2016-10-05 | VIIV Healthcare UK (No.5) Limited | Alquilamidas como inhibidores de la unión del VIH |
| ES2539908T3 (es) * | 2011-01-31 | 2015-07-07 | Bristol-Myers Squibb Company | Métodos de preparación de un compuesto profármaco inhibidor de la fijación del VIH e intermedios |
| EP2696937B1 (en) | 2011-04-12 | 2017-05-17 | VIIV Healthcare UK (No.5) Limited | Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors |
| ES2616268T3 (es) | 2011-08-29 | 2017-06-12 | VIIV Healthcare UK (No.5) Limited | Derivados condensados de diamina bicíclica como inhibidores de la unión de VIH |
| ES2609579T3 (es) | 2011-08-29 | 2017-04-21 | VIIV Healthcare UK (No.5) Limited | Derivados espiro de diamina bicíclica como inhibidores de la unión del VIH |
| US9193725B2 (en) | 2012-03-14 | 2015-11-24 | Bristol-Meyers Squibb Company | Cyclic hydrazine derivatives as HIV attachment inhibitors |
| ES2616492T3 (es) | 2012-08-09 | 2017-06-13 | VIIV Healthcare UK (No.5) Limited | Derivados de piperidina amida como inhibidores de la fijación del VIH |
| ES2616432T3 (es) | 2012-08-09 | 2017-06-13 | VIIV Healthcare UK (No.5) Limited | Derivados de alquenos tricíclicos como inhibidores de la unión del VIH |
| TW201946625A (zh) | 2013-11-15 | 2019-12-16 | 美商阿克比治療有限公司 | {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式，其組合物及用途 |
| RU2663466C1 (ru) * | 2017-03-20 | 2018-08-06 | Общество с ограниченной ответственностью "МБА-групп" | Композиция для профилактики и/или лечения вич-инфекции |
| CN110913861B (zh) | 2017-06-29 | 2024-01-09 | G1治疗公司 | G1t38的形态学形式及其制造方法 |
| KR102195348B1 (ko) | 2018-11-15 | 2020-12-24 | 에이치케이이노엔 주식회사 | 단백질 키나제 억제제로서의 신규 화합물 및 이를 포함하는 약제학적 조성물 |
| AU2020262100B2 (en) | 2019-04-24 | 2023-03-16 | Elanco Us Inc. | A 7H-pyrrolo[2,3-d]pyrimidine JAK-inhibitor |
| SG11202111907UA (en) | 2019-04-30 | 2021-11-29 | Beijing Tide Pharmaceutical Co Ltd | Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof |
| KR102886764B1 (ko) | 2019-06-06 | 2025-11-14 | 젠플리트 테라퓨틱스 (상하이) 아이엔씨. | Cdk9 억제제의 결정다형 및 이의 제조방법과 용도 |
| EP3996707A4 (en) | 2019-07-08 | 2023-02-22 | Rezolute, Inc. | CRYSTALLINE FORMS OF PLASMACALLICREIN INHIBITORS |
| PL4011881T3 (pl) | 2019-08-06 | 2025-04-07 | Wuxi Biocity Biopharmaceutics Co., Ltd. | Postacie krystaliczne inhibitora atr i ich zastosowanie |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB944443A (enExample) * | 1959-09-25 | 1900-01-01 | ||
| GB8615562D0 (en) * | 1986-06-25 | 1986-07-30 | Maggioni Farma | Aminoalcohols |
| WO1990007926A1 (en) | 1989-01-20 | 1990-07-26 | Pfizer Inc. | 3-(1,2,5,6-tetrahydropyridyl)-pyrrolopyridines |
| US5023265A (en) * | 1990-06-01 | 1991-06-11 | Schering Corporation | Substituted 1-H-pyrrolopyridine-3-carboxamides |
| IL99843A0 (en) | 1990-11-01 | 1992-08-18 | Merck & Co Inc | Synergistic combination of hiv reverse transcriptase inhibitors |
| US5811432A (en) * | 1990-11-09 | 1998-09-22 | Pfizer Inc | Azaoxindole derivatives |
| US5192770A (en) * | 1990-12-07 | 1993-03-09 | Syntex (U.S.A.) Inc. | Serotonergic alpha-oxoacetamides |
| DK0594702T3 (da) | 1991-07-03 | 1997-07-21 | Upjohn Co | Substituerede indoler som midler mod AIDS |
| US5124327A (en) * | 1991-09-06 | 1992-06-23 | Merck & Co., Inc. | HIV reverse transcriptase |
| WO1993005020A1 (en) | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
| US5413999A (en) * | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| IT1265057B1 (it) | 1993-08-05 | 1996-10-28 | Dompe Spa | Tropil 7-azaindolil-3-carbossiamidi |
| US5424329A (en) * | 1993-08-18 | 1995-06-13 | Warner-Lambert Company | Indole-2-carboxamides as inhibitors of cell adhesion |
| GB9420521D0 (en) | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
| GB9600559D0 (en) | 1996-01-11 | 1996-03-13 | British Biotech Pharm | Use of chemokines |
| CA2264231A1 (en) * | 1996-08-29 | 1998-03-05 | Takeda Chemical Industries, Ltd. | Cyclic ether compounds as sodium channel modulators |
| DE19636150A1 (de) * | 1996-09-06 | 1998-03-12 | Asta Medica Ag | N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung |
| WO1998028292A1 (en) | 1996-12-23 | 1998-07-02 | Smithkline Beecham Corporation | Novel piperidine containing compounds |
| AU1454599A (en) | 1997-11-10 | 1999-05-31 | Dana-Farber Cancer Institute | Compounds inhibiting cd4-gp120 interaction and uses thereof |
| RU2217421C2 (ru) | 1998-03-26 | 2003-11-27 | Шионоги & Ко., Лтд. | Производные индола, обладающие антивирусной активностью |
| DE19814838C2 (de) * | 1998-04-02 | 2001-01-18 | Asta Medica Ag | Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung |
| EP1091738B1 (en) | 1998-06-30 | 2006-12-06 | Eli Lilly And Company | BICYCLIC sPLA 2 INHIBITORS |
| EP1107758A2 (en) | 1998-08-28 | 2001-06-20 | Scios Inc. | Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| GB9905010D0 (en) | 1999-03-04 | 1999-04-28 | Merck Sharp & Dohme | Therapeutic agents |
| CZ20014126A3 (cs) | 1999-05-21 | 2002-03-13 | Scios Inc. | Indolové deriváty jako inhibitory p38 kinasy |
| US6469006B1 (en) | 1999-06-15 | 2002-10-22 | Bristol-Myers Squibb Company | Antiviral indoleoxoacetyl piperazine derivatives |
| TWI269654B (en) | 1999-09-28 | 2007-01-01 | Baxter Healthcare Sa | N-substituted indole-3-glyoxylamide compounds having anti-tumor action |
| US6476034B2 (en) * | 2000-02-22 | 2002-11-05 | Bristol-Myers Squibb Company | Antiviral azaindole derivatives |
| US20020061892A1 (en) | 2000-02-22 | 2002-05-23 | Tao Wang | Antiviral azaindole derivatives |
| DE60113543T2 (de) | 2000-07-10 | 2006-07-13 | Bristol-Myers Squibb Co. | Zusammensetzung und antivirale wirkung von substituierten indol-oxo-aceto-piperidin-derivaten |
| US6573262B2 (en) * | 2000-07-10 | 2003-06-03 | Bristol-Myers Sqibb Company | Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives |
| DE10037310A1 (de) | 2000-07-28 | 2002-02-07 | Asta Medica Ag | Neue Indolderivate und deren Verwendung als Arzneimittel |
| US20040110785A1 (en) * | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| KR20030079979A (ko) | 2001-02-02 | 2003-10-10 | 브리스톨-마이어스스퀴브컴파니 | 치환된 아자인돌옥소아세틱 피페라진 유도체의 조성물 및항바이러스 활성 |
| US20030207910A1 (en) * | 2001-02-02 | 2003-11-06 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US6825201B2 (en) | 2001-04-25 | 2004-11-30 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| BR0214020A (pt) | 2001-11-09 | 2004-10-13 | Scios Inc | Método para tratar fibrose cìstica |
| US20030236277A1 (en) | 2002-02-14 | 2003-12-25 | Kadow John F. | Indole, azaindole and related heterocyclic pyrrolidine derivatives |
| WO2003082881A2 (en) | 2002-03-28 | 2003-10-09 | Procyon Biopharma Inc. | Pyridoxal-5-phosphate derivatives as hiv integrase inhibitors |
| US7037913B2 (en) | 2002-05-01 | 2006-05-02 | Bristol-Myers Squibb Company | Bicyclo 4.4.0 antiviral derivatives |
| US20040063744A1 (en) * | 2002-05-28 | 2004-04-01 | Tao Wang | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| US7348337B2 (en) * | 2002-05-28 | 2008-03-25 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides |
| US20040106104A1 (en) | 2002-06-11 | 2004-06-03 | Pin-Fang Lin | Viral envelope mediated fusion assay |
| US6900206B2 (en) * | 2002-06-20 | 2005-05-31 | Bristol-Myers Squibb Company | Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives |
| US20040063746A1 (en) * | 2002-07-25 | 2004-04-01 | Alicia Regueiro-Ren | Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives |
| US20050075364A1 (en) * | 2003-07-01 | 2005-04-07 | Kap-Sun Yeung | Indole, azaindole and related heterocyclic N-substituted piperazine derivatives |
| OA13235A (en) | 2003-08-14 | 2006-12-13 | Pfizer | Piperazine derivatives for the treatment of HIV infections. |
| US20050124623A1 (en) * | 2003-11-26 | 2005-06-09 | Bender John A. | Diazaindole-dicarbonyl-piperazinyl antiviral agents |
| US7745625B2 (en) * | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| US20050215544A1 (en) * | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
| US7776863B2 (en) * | 2004-03-24 | 2010-08-17 | Bristol-Myers Squibb Company | Methods of treating HIV infection |
| US20050215543A1 (en) * | 2004-03-24 | 2005-09-29 | Pin-Fang Lin | Methods of treating HIV infection |
| US7449476B2 (en) * | 2004-05-26 | 2008-11-11 | Bristol-Myers Squibb Company | Tetrahydrocarboline antiviral agents |
| US7087610B2 (en) * | 2004-06-03 | 2006-08-08 | Bristol-Myers Squibb Company | Benzothiazole antiviral agents |
| WO2005121094A1 (en) | 2004-06-09 | 2005-12-22 | Pfizer Limited | Piperazine and piperidine derivatives as anti-hiv-agents |
| US20060100432A1 (en) * | 2004-11-09 | 2006-05-11 | Matiskella John D | Crystalline materials of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| US20060100209A1 (en) * | 2004-11-09 | 2006-05-11 | Chong-Hui Gu | Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione |
| US7183284B2 (en) * | 2004-12-29 | 2007-02-27 | Bristol-Myers Squibb Company | Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| US7396830B2 (en) * | 2005-10-04 | 2008-07-08 | Bristol-Myers Squibb Company | Piperazine amidines as antiviral agents |
| US7807671B2 (en) * | 2006-04-25 | 2010-10-05 | Bristol-Myers Squibb Company | Diketo-piperazine and piperidine derivatives as antiviral agents |
| US7501419B2 (en) * | 2006-04-25 | 2009-03-10 | Bristol-Myers Squibb Company | 4-Squarylpiperazine derivatives as antiviral agents |
-
2006
- 2006-12-11 US US11/636,755 patent/US7851476B2/en active Active
- 2006-12-13 CN CN2006800472167A patent/CN101365708B/zh active Active
- 2006-12-13 KR KR1020087016884A patent/KR20080077010A/ko not_active Ceased
- 2006-12-13 CA CA002635717A patent/CA2635717A1/en not_active Abandoned
- 2006-12-13 JP JP2008545772A patent/JP5400387B2/ja active Active
- 2006-12-13 AU AU2006326432A patent/AU2006326432B2/en active Active
- 2006-12-13 EA EA200801529A patent/EA014706B1/ru not_active IP Right Cessation
- 2006-12-13 WO PCT/US2006/047571 patent/WO2007070589A2/en not_active Ceased
- 2006-12-13 MY MYPI20082090A patent/MY144293A/en unknown
- 2006-12-13 NZ NZ592684A patent/NZ592684A/en unknown
- 2006-12-13 NZ NZ568776A patent/NZ568776A/en unknown
- 2006-12-13 GE GEAP200610811A patent/GEP20125413B/en unknown
- 2006-12-13 BR BRPI0619851-1A patent/BRPI0619851A2/pt not_active Application Discontinuation
- 2006-12-13 EP EP06848592A patent/EP1963342A2/en not_active Withdrawn
- 2006-12-13 UA UAA200809079A patent/UA94928C2/ru unknown
-
2008
- 2008-05-27 IL IL191769A patent/IL191769A/en active IP Right Grant
- 2008-05-29 NO NO20082477A patent/NO20082477L/no not_active Application Discontinuation
- 2008-06-10 ZA ZA200805063A patent/ZA200805063B/xx unknown